We are 5-Octanoylsalicylic acid CAS:78418-01-6 manufacturer and supplier in China, Pls send inquiry of to email@example.com of visit www.nbinno.com our official website should you have any interests
CAS No: 78418-01-6
Product Name: 2-Hydroxy-5-octanoylbenzoic acid
capryloyl salicylic acid
Density: 1.1±0.1 g/cm3
Boiling Point: 454.8±35.0 °C at 760 mmHg
Molecular Formula: C15H20O4
Molecular Weight: 264.317
Flash Point: 243.0±22.4 °C
Exact Mass: 264.136169
Vapour Pressure: 0.0±1.2 mmHg at 25°C
Index of Refraction: 1.544
Appearance: White crystalline powder
Residue on ignition: ≤0.4%
It has a whitening and lightening effect, improves skin moisturizing ability, and improves skin elasticity.
Caprylyl salicylic acid is used as a cuticle separating agent, acne remover, whitening agent, anti-aging agent, and is used in cosmetics and skin medicinal ingredients.It can especially improve the clinical manifestations of skin aging-often called wrinkles and fine lines. It also restores skin that has lost firmness and elasticity.
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Related News: Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.N-cyclohexyl-N-[2-(4-methyl-1-oxa-4-azoniacyclohex-4-yl)ethyl]methanediimine,4-methylbenzenesulfonic acid CAS:2491-17-0 Patents covering oral and injectable rigosertib have been issued in the US and are expected to provide coverage until at least 2037.N – [(4-fluorofenil) metil] -1-metilpiperidin-4-amina CAS:359878-47-0 The drug review center will establish a registration platform and database for APIs, pharmaceutical excipients and pharmaceutical packaging materials, which means that the domestic drug substance DMF system is expected to be gradually implemented.402936-15-6 Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.Only when the drug substance is processed into a pharmaceutical preparation can it become a drug for clinical application.